Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.

Gouldson P, Calandra B, Legoux P, Kernéis A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D.

Eur J Pharmacol. 2000 Jul 28;401(1):17-25.

PMID:
10915832
2.

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P, Ferrara P.

Life Sci. 1999;65(6-7):627-35. Review.

PMID:
10462063
3.

Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.

Calandra B, Portier M, Kernéis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D.

Eur J Pharmacol. 1999 Jun 25;374(3):445-55.

PMID:
10422789
4.

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Portier M, Rinaldi-Carmona M, Pecceu F, Combes T, Poinot-Chazel C, Calandra B, Barth F, le Fur G, Casellas P.

J Pharmacol Exp Ther. 1999 Feb;288(2):582-9.

PMID:
9918562
5.

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Brelière JC, Le Fur GL.

J Pharmacol Exp Ther. 1998 Feb;284(2):644-50.

PMID:
9454810
6.

A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.

Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P.

J Biol Chem. 1997 Aug 29;272(35):22330-9.

7.

Characterization of two cloned human CB1 cannabinoid receptor isoforms.

Rinaldi-Carmona M, Calandra B, Shire D, Bouaboula M, Oustric D, Barth F, Casellas P, Ferrara P, Le Fur G.

J Pharmacol Exp Ther. 1996 Aug;278(2):871-8.

PMID:
8768742
8.

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessègue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P.

Biochim Biophys Acta. 1996 Jun 7;1307(2):132-6.

PMID:
8679694
9.

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrié B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P.

Eur J Biochem. 1996 May 1;237(3):704-11.

10.

Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.

Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P.

J Biol Chem. 1996 Mar 22;271(12):6941-6.

11.

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Bouaboula M, Poinot-Chazel C, Bourrié B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P.

Biochem J. 1995 Dec 1;312 ( Pt 2):637-41.

12.

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.

Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P.

J Biol Chem. 1995 Feb 24;270(8):3726-31. Erratum in: J Biol Chem 1996 Dec 27;271(52):33706.

13.

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, et al.

FEBS Lett. 1994 Aug 22;350(2-3):240-4.

Supplemental Content

Loading ...
Support Center